Literature DB >> 19015649

Should serial assessment of bone turnover markers be included in fracture risk calculation in elderly women?

Samuel D Vasikaran1.   

Abstract

Entities:  

Year:  2008        PMID: 19015649     DOI: 10.1038/ncpendmet1018

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


× No keyword cloud information.
  5 in total

Review 1.  Preanalytical variability of biochemical markers of bone turnover.

Authors:  R Hannon; R Eastell
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

Review 2.  The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

Authors:  P D Delmas; R Eastell; P Garnero; M J Seibel; J Stepan
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

3.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

4.  Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk.

Authors:  Kaisa K Ivaska; Janaka Lenora; Paul Gerdhem; Kristina Akesson; H Kalervo Väänänen; Karl J Obrant
Journal:  J Clin Endocrinol Metab       Date:  2008-05-06       Impact factor: 5.958

Review 5.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507

  5 in total
  2 in total

Review 1.  Bone management in hematologic stem cell transplant recipients.

Authors:  D L Kendler; J J Body; M L Brandi; R Broady; J Cannata-Andia; M J Cannata-Ortiz; A El Maghraoui; G Guglielmi; P Hadji; D D Pierroz; T J de Villiers; R Rizzoli; P R Ebeling
Journal:  Osteoporos Int       Date:  2018-09-03       Impact factor: 4.507

2.  Bone turnover in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Mitchell A Watsky; Laura D Carbone; Qi An; Cheng Cheng; Elizabeth A Lovorn; Melissa M Hudson; Ching-Hon Pui; Sue C Kaste
Journal:  Pediatr Blood Cancer       Date:  2014-03-20       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.